Total Payments
$15,430
2024 Payments
$1,860
Companies
40
Transactions
693
Medicare Patients
8,332
Medicare Billing
$1.1M
Payment Breakdown by Category
Food & Beverage$11,868 (76.9%)
Consulting$3,000 (19.4%)
Travel$458.40 (3.0%)
Education$102.85 (0.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,868 | 689 | 76.9% |
| Consulting Fee | $3,000 | 1 | 19.4% |
| Travel and Lodging | $458.40 | 1 | 3.0% |
| Education | $102.85 | 2 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $4,286 | 64 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $1,691 | 85 | $0 (2024) |
| ABBVIE INC. | $1,581 | 78 | $0 (2024) |
| Amgen Inc. | $1,139 | 59 | $0 (2024) |
| Lilly USA, LLC | $939.74 | 48 | $0 (2024) |
| Incyte Corporation | $625.51 | 44 | $0 (2024) |
| PFIZER INC. | $599.40 | 91 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $563.26 | 28 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $495.06 | 24 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $461.09 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,860 | 104 | SUN PHARMACEUTICAL INDUSTRIES INC. ($341.93) |
| 2023 | $1,485 | 87 | Sun Pharmaceutical Industries Inc. ($241.08) |
| 2022 | $1,248 | 59 | Sun Pharmaceutical Industries Inc. ($341.84) |
| 2021 | $1,055 | 54 | AbbVie Inc. ($456.84) |
| 2020 | $1,585 | 92 | AbbVie Inc. ($432.35) |
| 2019 | $1,720 | 116 | Janssen Scientific Affairs, LLC ($249.62) |
| 2018 | $1,344 | 92 | Amgen Inc. ($263.14) |
| 2017 | $5,133 | 89 | Janssen Biotech, Inc. ($3,705) |
All Payment Transactions
693 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $19.32 | General |
| Category: Dermatology | ||||||
| 12/19/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $0.85 | General |
| Category: Dermatology | ||||||
| 12/17/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: Dermatology | ||||||
| 12/06/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: Immunology | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $5.81 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: Dermatology | ||||||
| 11/20/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $25.42 | General |
| Category: Dermatology | ||||||
| 11/19/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $34.46 | General |
| Category: Inflammation | ||||||
| 11/14/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.70 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: Immunology | ||||||
| 11/04/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $19.28 | General |
| Category: Dermatology | ||||||
| 11/04/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $0.43 | General |
| Category: Dermatology | ||||||
| 10/30/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Immunology | ||||||
| 10/28/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Obesity | ||||||
| 10/24/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: Dermatology | ||||||
| 10/23/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $25.81 | General |
| Category: Dermatology | ||||||
| 10/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: DERMATOLOGY | ||||||
| 10/08/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: Immunology | ||||||
| 10/03/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $31.68 | General |
| Category: Dermatology | ||||||
| 10/01/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $15.65 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,459 | 2,221 | $930,774 | $214,347 |
| 2022 | 27 | 1,711 | 2,578 | $1.0M | $231,853 |
| 2021 | 29 | 2,384 | 3,521 | $1.4M | $322,064 |
| 2020 | 31 | 2,778 | 4,349 | $1.6M | $344,509 |
Total Patients
8,332
Total Services
12,669
Medicare Billing
$1.1M
Procedure Codes
110
All Medicare Procedures & Services
110 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 119 | 151 | $299,188 | $72,016 | 24.1% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 68 | 119 | $143,011 | $37,977 | 26.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 143 | 181 | $67,445 | $16,181 | 24.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 166 | 234 | $61,612 | $14,974 | 24.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 144 | 164 | $54,314 | $12,326 | 22.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 127 | 148 | $43,853 | $8,668 | 19.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 117 | 117 | $38,168 | $8,058 | 21.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 73 | 73 | $35,420 | $6,787 | 19.2% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2023 | 12 | 12 | $22,317 | $5,318 | 23.8% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 23 | 26 | $23,112 | $4,394 | 19.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 74 | 101 | $16,617 | $4,022 | 24.2% |
| 12051 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.5 cm or less | Office | 2023 | 24 | 25 | $20,770 | $3,803 | 18.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 95 | 116 | $22,723 | $3,751 | 16.5% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 15 | 15 | $20,718 | $2,952 | 14.3% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 38 | 62 | $9,107 | $2,435 | 26.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 79 | 480 | $9,364 | $2,423 | 25.9% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 24 | 26 | $10,071 | $2,292 | 22.8% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2023 | 12 | 12 | $11,103 | $1,607 | 14.5% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 29 | 29 | $6,103 | $1,401 | 23.0% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 12 | 12 | $5,896 | $1,362 | 23.1% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 24 | 30 | $4,995 | $1,091 | 21.8% |
| 69100 | Biopsy of ear | Office | 2023 | 11 | 12 | $3,387 | $452.41 | 13.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 30 | 76 | $1,480 | $55.56 | 3.8% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2022 | 104 | 147 | $290,821 | $69,175 | 23.8% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2022 | 62 | 113 | $136,070 | $35,543 | 26.1% |
About Dr. Adrian Guevara, MD
Dr. Adrian Guevara, MD is a MOHS-Micrographic Surgery healthcare provider based in El Paso, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104898188.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Adrian Guevara, MD has received a total of $15,430 in payments from pharmaceutical and medical device companies, with $1,860 received in 2024. These payments were reported across 693 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($11,868).
As a Medicare-enrolled provider, Guevara has provided services to 8,332 Medicare beneficiaries, totaling 12,669 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 110 distinct procedure/service records.
Ad
Practice Information
- Specialty MOHS-Micrographic Surgery
- Other Specialties Dermatology
- Location El Paso, TX
- Active Since 02/03/2006
- Last Updated 02/20/2023
- Taxonomy Code 207ND0101X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1104898188
Products in Payments
- TALTZ (Drug) $893.63
- ILUMYA (Biological) $815.07
- SKYRIZI (Biological) $762.14
- Enbrel (Biological) $743.40
- OPZELURA (Drug) $625.51
- EUCRISA (Drug) $599.40
- Otezla (Drug) $474.10
- DUPIXENT (Biological) $442.57
- Humira (Biological) $422.05
- STELARA (Biological) $372.61
- Sotyktu (Drug) $334.95
- Tremfya (Drug) $329.80
- VTAMA (Drug) $278.73
- TREMFYA (Drug) $268.75
- HUMIRA (Biological) $256.79
- Winlevi (Drug) $253.29
- Cimzia (Drug) $244.61
- COSENTYX (Drug) $236.50
- REMICADE (Biological) $217.30
- DUPIXENT (Drug) $211.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.